SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study

por Kokai-Kun, John, Roberts, Tracey, Coughlin, Olivia, Whalen, Heidi, Le, Charles, Da Costa, Christopher, Sliman, Joseph
Publicado 2017

The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies

por Kokai-Kun, John F., Roberts, Tracey, Coughlin, Olivia, Sicard, Eric, Rufiange, Marianne, Fedorak, Richard, Carter, Christian, Adams, Marijke H., Longstreth, James, Whalen, Heidi, Sliman, Joseph
Publicado 2017

The impact of preoperative oral nutrition supplementation on outcomes in patients undergoing gastrointestinal surgery for cancer in low- and middle-income countries: a systematic r...

por Knight, Stephen R., Qureshi, Ahmad U., Drake, Thomas M., Lapitan, Marie Carmela M., Maimbo, Mayaba, Yenli, Edwin, Tabiri, Stephen, Ghosh, Dhruva, Kingsley, Pamela A., Sundar, Sudha, Shaw, Catherine, Valparaiso, Apple P., Bhangu, Aneel, Brocklehurst, Peter, Magill, Laura, Morton, Dion G., Norrie, John, Roberts, Tracey E., Theodoratou, Evropi, Weiser, Thomas G., Burden, Sorrel, Harrison, Ewen M.
Publicado 2022